Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
200 mg | Warenkorb auf Verfügbarkeit prüfen | € 425,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
isoflupredone
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
F[C@@]21[C@H]([C@H]4[C@@]([C@@](CC4)(O)C(=O)COC(=O)C)(C[C@@H]2O)C)CCC3=CC(=O)C=C[C@@]31C
InChI
1S/C23H29FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h6,8,10,16-18,27,29H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1
InChI key
ZOCUOMKMBMEYQV-GSLJADNHSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Isoflupredone Acetate Injectable Suspension
- Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Ointment
- Neomycin Sulfate, Isoflupredone Acetate, and Tetracaine Hydrochloride Topical Powder
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| format neat | format neat | format neat | format neat |
| API family isoflupredone | API family fludrocortisone | API family fluorometholone | API family methylprednisolone |
Still not finding the right product?
Explore all of our products under Isoflupredonacetat
Lagerklasse
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

